CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Return
4.23%
This Quarter Return
+3.11%
1 Year Return
-4.23%
3 Year Return
+26.63%
5 Year Return
+47.71%
10 Year Return
+121.3%
AUM
$1.6B
AUM Growth
-$954M
(-37%)
Cap. Flow
-$930M
Cap. Flow
% of AUM
-58%
Top 10 Holdings %
Top 10 Hldgs %
75.77%
Holding
38
New
–
Increased
7
Reduced
16
Closed
8
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$73M |
| 2 |
Baxter International
BAX
|
$38.5M |
| 3 |
Humana
HUM
|
$19.8M |
| 4 |
Cigna
CI
|
$16.5M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$3.53M |
Top Sells
| 1 |
Medtronic
MDT
|
$220M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
$142M |
| 3 |
PTC Therapeutics
PTCT
|
$86.6M |
| 4 |
GSK
GSK
|
$84.6M |
| 5 |
Ascendis Pharma
ASND
|
$70.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Structure Therapeutics
GPCR
$1.2B
| $5.19M | 0.18% |
300,000
| – | – |
|
27
OraSure Technologies
OSUR
$238M
| $3.03M | 0.11% |
900,000
-3,350,000
| -79% | -$11.3M |
|
28
Genmab
GMAB
$16.9B
| $979K | 0.03% |
50,000
| – | – |
|
29
Alkermes
ALKS
$4.7B
| – | – |
-1,500,000
| Closed | -$43.1M |
|
|
30
GSK
GSK
$80.6B
| – | – |
-2,500,000
| Closed | -$84.6M |
|
31
Herbalife
HLF
$1.02B
| – | – |
-3,000,000
| Closed | -$20.1M |
|
|
32
Jazz Pharmaceuticals
JAZZ
$7.88B
| – | – |
-1,150,000
| Closed | -$142M |
|
|
33
Medtronic
MDT
$119B
| – | – |
-2,750,000
| Closed | -$220M |
|
34
Medpace
MEDP
$13.8B
| – | – |
-125,000
| Closed | -$41.5M |
|
35
Merus
MRUS
$5.08B
| – | – |
-250,000
| Closed | -$10.5M |
|
36
SPDR S&P 500 ETF Trust
SPY
$662B
| – | – |
0
| – | – |
|
37
SPDR S&P Biotech ETF
XBI
$5.33B
| – | – |
0
| – | – |
|
|
BKDT
38
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| – | – |
-250,000
| Closed | -$17.2M |
|